These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20035387)

  • 1. Treatment of newly diagnosed multiple myeloma: advances in current therapy.
    Kumar S
    Med Oncol; 2010 Jun; 27 Suppl 1():S14-24. PubMed ID: 20035387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multiple myeloma.
    Rajkumar SV
    Nat Rev Clin Oncol; 2011 Apr; 8(8):479-91. PubMed ID: 21522124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma.
    Marneni N; Chakraborty R
    Curr Hematol Malig Rep; 2021 Apr; 16(2):148-161. PubMed ID: 33876390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical treatment of newly diagnosed multiple myeloma.
    Cejalvo MJ; de la Rubia J
    Expert Rev Hematol; 2015 Oct; 8(5):595-611. PubMed ID: 26327587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis.
    Thoennissen GB; Görlich D; Bacher U; Aufenberg T; Hüsken AC; Hansmeier AA; Evers G; Mikesch JH; Fritz F; Bokemeyer C; Müller-Tidow C; Stelljes M; Mesters RM; Krug U; Kropff MH; Thoennissen NH; Berdel WE
    Acta Haematol; 2017; 137(3):163-172. PubMed ID: 28399522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontline therapy of multiple myeloma.
    Moreau P; Attal M; Facon T
    Blood; 2015 May; 125(20):3076-84. PubMed ID: 25838345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network.
    Ozaki S; Harada T; Saitoh T; Shimazaki C; Itagaki M; Asaoku H; Kuroda Y; Chou T; Yoshiki Y; Suzuki K; Murakami H; Hayashi K; Mina R; Palumbo A; Shimizu K; ;
    Acta Haematol; 2014; 132(2):211-9. PubMed ID: 24662986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modern treatments and future directions for newly diagnosed multiple myeloma patients.
    Lu SX
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101151. PubMed ID: 32139016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial Therapeutic Approaches to Patients with Multiple Myeloma.
    Berbari HE; Kumar SK
    Adv Ther; 2021 Jul; 38(7):3694-3711. PubMed ID: 34145483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional therapy and approach to management.
    Rajkumar SV; Kyle RA
    Best Pract Res Clin Haematol; 2005; 18(4):585-601. PubMed ID: 16026739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma.
    Laubach J; Kumar S
    Cancer Treat Res; 2016; 169():145-167. PubMed ID: 27696262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma: Every year a new standard?
    Rajkumar SV
    Hematol Oncol; 2019 Jun; 37 Suppl 1(Suppl 1):62-65. PubMed ID: 31187526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloma and the newly diagnosed patient: a focus on treatment and management.
    Rajkumar SV; Kyle RA; Gertz MA
    Semin Oncol; 2002 Dec; 29(6 Suppl 17):5-10. PubMed ID: 12520478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].
    Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J
    Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple myeloma: diagnosis and treatment.
    Rajkumar SV; Kyle RA
    Mayo Clin Proc; 2005 Oct; 80(10):1371-82. PubMed ID: 16212152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in the management of newly diagnosed multiple myeloma.
    Reece DE
    Curr Opin Hematol; 2009 Jul; 16(4):306-12. PubMed ID: 19491669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches to management of high-risk multiple myeloma.
    Goldman-Mazur S; Kumar SK
    Am J Hematol; 2021 Jul; 96(7):854-871. PubMed ID: 33725367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of newly diagnosed multiple myeloma.
    Palumbo A; Magarotto V; Larocca A; Bringhen S; Falco P; Di Raimondo F; Baldini L; Boccadoro M
    Curr Hematol Malig Rep; 2008 Apr; 3(2):107-14. PubMed ID: 20425454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction therapy of transplant-eligible patients in multiple myeloma].
    Konishi J; Sunami K
    Nihon Rinsho; 2015 Jan; 73(1):90-4. PubMed ID: 25626311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.